Latest Insider Transactions at Molina Healthcare, Inc. (MOH)
This section provides a real-time view of insider transactions for Molina Healthcare, Inc. (MOH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MOLINA HEALTHCARE, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MOLINA HEALTHCARE, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2023
|
Mark Lowell Keim Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,324
+20.8%
|
$8,278,452
$273.08 P/Share
|
|
Mar 01
2023
|
Maurice Hebert Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,382
-7.91%
|
$377,286
$273.8 P/Share
|
|
Mar 01
2023
|
Maurice Hebert Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,382
+14.91%
|
$923,286
$273.8 P/Share
|
|
Mar 01
2023
|
Joseph M Zubretsky President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
78,323
-10.98%
|
$21,382,179
$273.8 P/Share
|
|
Mar 01
2023
|
Joseph M Zubretsky President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
157,282
+16.76%
|
$42,937,986
$273.44 P/Share
|
|
Mar 01
2023
|
James Woys Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,153
-8.22%
|
$2,498,769
$273.8 P/Share
|
|
Mar 01
2023
|
James Woys Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,697
+17.63%
|
$6,742,281
$273.8 P/Share
|
|
Mar 01
2023
|
Marc Russo EVP, Health Plans |
SELL
Payment of exercise price or tax liability
|
Direct |
20,780
-19.74%
|
$5,672,940
$273.8 P/Share
|
|
Mar 01
2023
|
Marc Russo EVP, Health Plans |
BUY
Grant, award, or other acquisition
|
Direct |
47,062
+30.36%
|
$12,847,926
$273.8 P/Share
|
|
Jan 01
2023
|
Barbara L Brasier Director |
BUY
Grant, award, or other acquisition
|
Direct |
167
+3.7%
|
$55,110
$330.22 P/Share
|
|
Jan 01
2023
|
Steven J Orlando Director |
BUY
Grant, award, or other acquisition
|
Indirect |
167
+0.8%
|
$55,110
$330.22 P/Share
|
|
Jan 01
2023
|
Ronna Romney Director |
BUY
Grant, award, or other acquisition
|
Indirect |
167
+0.99%
|
$55,110
$330.22 P/Share
|
|
Jan 01
2023
|
Richard C Zoretic Director |
BUY
Grant, award, or other acquisition
|
Indirect |
167
+2.89%
|
$55,110
$330.22 P/Share
|
|
Jan 01
2023
|
Daniel Cooperman Director |
BUY
Grant, award, or other acquisition
|
Direct |
167
+3.27%
|
$55,110
$330.22 P/Share
|
|
Jan 01
2023
|
Stephen H Lockhart Director |
BUY
Grant, award, or other acquisition
|
Direct |
167
+10.6%
|
$55,110
$330.22 P/Share
|
|
Jan 01
2023
|
Dale B Wolf Director |
BUY
Grant, award, or other acquisition
|
Direct |
167
+1.06%
|
$55,110
$330.22 P/Share
|
|
Jan 01
2023
|
Richard M Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
167
+1.35%
|
$55,110
$330.22 P/Share
|
|
Dec 12
2022
|
Marc Russo EVP, Health Plans |
SELL
Open market or private sale
|
Direct |
1,500
-8.82%
|
$526,500
$351.17 P/Share
|
|
Dec 07
2022
|
Dale B Wolf Director |
SELL
Open market or private sale
|
Direct |
2,500
-3.64%
|
$850,000
$340.1 P/Share
|
|
Nov 29
2022
|
Joseph M Zubretsky President & CEO |
SELL
Bona fide gift
|
Direct |
4,600
-1.8%
|
-
|
|
Nov 07
2022
|
Ronna Romney Director |
SELL
Open market or private sale
|
Indirect |
150
-0.9%
|
$49,650
$331.56 P/Share
|
|
Nov 07
2022
|
Dale B Wolf Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+25.01%
|
$198,000
$33.02 P/Share
|
|
Oct 31
2022
|
Richard M Schapiro Director |
SELL
Open market or private sale
|
Direct |
3,000
-10.12%
|
$1,065,000
$355.15 P/Share
|
|
Oct 07
2022
|
Joseph M Zubretsky President & CEO |
SELL
Open market or private sale
|
Direct |
28,914
-1.52%
|
$10,004,244
$346.14 P/Share
|
|
Oct 07
2022
|
Joseph M Zubretsky President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
28,914
+9.24%
|
$1,937,238
$67.33 P/Share
|
|
Oct 06
2022
|
Joseph M Zubretsky President & CEO |
SELL
Open market or private sale
|
Direct |
30,000
-2.19%
|
$10,620,000
$354.55 P/Share
|
|
Oct 06
2022
|
Joseph M Zubretsky President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+9.52%
|
$2,010,000
$67.33 P/Share
|
|
Oct 05
2022
|
Joseph M Zubretsky President & CEO |
SELL
Open market or private sale
|
Direct |
30,000
-1.38%
|
$10,470,000
$349.18 P/Share
|
|
Oct 05
2022
|
Joseph M Zubretsky President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+9.52%
|
$2,010,000
$67.33 P/Share
|
|
Oct 04
2022
|
Joseph M Zubretsky President & CEO |
SELL
Open market or private sale
|
Direct |
30,000
-1.37%
|
$10,260,000
$342.81 P/Share
|
|
Oct 04
2022
|
Joseph M Zubretsky President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+9.52%
|
$2,010,000
$67.33 P/Share
|
|
Oct 03
2022
|
Joseph M Zubretsky President & CEO |
SELL
Open market or private sale
|
Direct |
30,000
-1.22%
|
$10,050,000
$335.41 P/Share
|
|
Oct 03
2022
|
Joseph M Zubretsky President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+9.52%
|
$2,010,000
$67.33 P/Share
|
|
Oct 01
2022
|
Richard M Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
167
+1.1%
|
$54,943
$329.84 P/Share
|
|
Oct 01
2022
|
Ronna Romney Director |
BUY
Grant, award, or other acquisition
|
Indirect |
167
+0.99%
|
$54,943
$329.84 P/Share
|
|
Oct 01
2022
|
Dale B Wolf Director |
BUY
Grant, award, or other acquisition
|
Direct |
167
+1.37%
|
$54,943
$329.84 P/Share
|
|
Oct 01
2022
|
Richard C Zoretic Director |
BUY
Grant, award, or other acquisition
|
Indirect |
167
+2.97%
|
$54,943
$329.84 P/Share
|
|
Oct 01
2022
|
Steven J Orlando Director |
BUY
Grant, award, or other acquisition
|
Indirect |
167
+0.81%
|
$54,943
$329.84 P/Share
|
|
Oct 01
2022
|
Stephen H Lockhart Director |
BUY
Grant, award, or other acquisition
|
Direct |
167
+11.85%
|
$54,943
$329.84 P/Share
|
|
Oct 01
2022
|
Maurice Hebert Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
113
-1.54%
|
$37,177
$329.84 P/Share
|
|
Oct 01
2022
|
Daniel Cooperman Director |
BUY
Grant, award, or other acquisition
|
Direct |
167
+3.38%
|
$54,943
$329.84 P/Share
|
|
Oct 01
2022
|
Barbara L Brasier Director |
BUY
Grant, award, or other acquisition
|
Direct |
167
+3.85%
|
$54,943
$329.84 P/Share
|
|
Sep 30
2022
|
Joseph M Zubretsky President & CEO |
SELL
Open market or private sale
|
Direct |
30,000
-1.38%
|
$10,020,000
$334.06 P/Share
|
|
Sep 30
2022
|
Joseph M Zubretsky President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+9.52%
|
$2,010,000
$67.33 P/Share
|
|
Sep 29
2022
|
Joseph M Zubretsky President & CEO |
SELL
Open market or private sale
|
Direct |
30,000
-3.6%
|
$9,930,000
$331.76 P/Share
|
|
Sep 29
2022
|
Joseph M Zubretsky President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+9.52%
|
$2,010,000
$67.33 P/Share
|
|
Sep 28
2022
|
Joseph M Zubretsky President & CEO |
SELL
Open market or private sale
|
Direct |
30,000
-1.83%
|
$9,960,000
$332.98 P/Share
|
|
Sep 28
2022
|
Joseph M Zubretsky President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+9.52%
|
$2,010,000
$67.33 P/Share
|
|
Sep 27
2022
|
Joseph M Zubretsky President & CEO |
SELL
Open market or private sale
|
Direct |
18,210
-1.69%
|
$6,027,510
$331.9 P/Share
|
|
Sep 27
2022
|
Joseph M Zubretsky President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,210
+6.25%
|
$1,220,070
$67.33 P/Share
|